Karrine Brade, PharmD
@bradeka.bsky.social
ID Pharmacy Supervisor @UCHealth | Abx Stewardship nerd | Dog mom | She/Her #pharmsky #medsky #IDsky
Reposted by Karrine Brade, PharmD
Come work as an ID pharmacist at @ucsfhealth.bsky.social! See the craziest cases, collaborate with the coolest pharmacists and physicians, teach trainees from pharmacy students to ID fellows!
sjobs.brassring.com/TGnewUI/Sear...
sjobs.brassring.com/TGnewUI/Sear...
Infectious Diseases Pharmacotherapy Specialist - University of California San Francisco - Job Details
Job Details: The Department of Pharmaceutical Services provides a full range of services for patients cared for by the Medi
sjobs.brassring.com
October 10, 2025 at 2:20 PM
Come work as an ID pharmacist at @ucsfhealth.bsky.social! See the craziest cases, collaborate with the coolest pharmacists and physicians, teach trainees from pharmacy students to ID fellows!
sjobs.brassring.com/TGnewUI/Sear...
sjobs.brassring.com/TGnewUI/Sear...
Reposted by Karrine Brade, PharmD
You've Got a Friend in Me: Curbside Questions Infectious Diseases Clinicians Ask Infectious Diseases Pharmacists
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
You've Got a Friend in Me: Curbside Questions Infectious Diseases Clinicians Ask Infectious Diseases Pharmacists
This multicenter study highlights the critical role of ID pharmacists in supporting ID consult services, with 89% of 1,518 curbside inquiries from ID clinicians resulting in clinical management changes as recommended by the pharmacist. These findings emphasize the necessity of ID pharmacists in optimizing multidisciplinary patient care.
doi.org
May 17, 2025 at 6:58 PM
You've Got a Friend in Me: Curbside Questions Infectious Diseases Clinicians Ask Infectious Diseases Pharmacists
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Reposted by Karrine Brade, PharmD
(1/2) Last week, 33 ID professionals gathered in Arlington, VA for IDSA’s Community of Leaders, a training program designed to equip mid- and senior-level professionals with the tools, insights, and network to drive career growth and lead meaningful change.
May 12, 2025 at 6:52 PM
(1/2) Last week, 33 ID professionals gathered in Arlington, VA for IDSA’s Community of Leaders, a training program designed to equip mid- and senior-level professionals with the tools, insights, and network to drive career growth and lead meaningful change.
Reposted by Karrine Brade, PharmD
Our Division hosted the inaugural 2025 Colorado Infectious Diseases Symposium on April 19. The event was a tremendous success, uniting experts from across the state to advance learning, enhance collegiality, and improve health outcomes for patients in Colorado! A proud moment for #ColoradoID!
April 25, 2025 at 5:58 PM
Our Division hosted the inaugural 2025 Colorado Infectious Diseases Symposium on April 19. The event was a tremendous success, uniting experts from across the state to advance learning, enhance collegiality, and improve health outcomes for patients in Colorado! A proud moment for #ColoradoID!
Reposted by Karrine Brade, PharmD
We’re expanding our stewardship program - help pioneer our contractual ASP initiative! This position will participate in our systemwide ASP program by establishing stewardship practices at MUSC Health affiliate sites! DM with any questions!
musc.wd1.myworkdayjobs.com/MUSC/job/SCM...
musc.wd1.myworkdayjobs.com/MUSC/job/SCM...
Antimicrobial Stewardship Pharmacist
Job Description Summary The Clinical Pharmacy Specialist, Infectious Diseases/Antimicrobial Stewardship will participate in systemwide stewardship responsibilities, including MUSC facilities and MUSC ...
musc.wd1.myworkdayjobs.com
April 9, 2025 at 2:29 PM
We’re expanding our stewardship program - help pioneer our contractual ASP initiative! This position will participate in our systemwide ASP program by establishing stewardship practices at MUSC Health affiliate sites! DM with any questions!
musc.wd1.myworkdayjobs.com/MUSC/job/SCM...
musc.wd1.myworkdayjobs.com/MUSC/job/SCM...
Reposted by Karrine Brade, PharmD
Three new UTI antibiotics active vs. ESBL organisms have been approved by the FDA in the past year alone! Which will make it to market first: pivmecillinam, sulopenem-probenecid, or gepotidacin? #IDsky
March 27, 2025 at 1:41 PM
Three new UTI antibiotics active vs. ESBL organisms have been approved by the FDA in the past year alone! Which will make it to market first: pivmecillinam, sulopenem-probenecid, or gepotidacin? #IDsky
Reposted by Karrine Brade, PharmD
IT’S A BREAKPOINTS BREAKOUT!!!
This week @erinmccreary.bsky.social & @juliejusto.bsky.social from @sidpharm.bsky.social #Breakpoints podcast join Callum & Jame to show ‘em how it’s done and discuss the IDSA Difficult-to-Treat Gram Negative guidance!!
podcasts.apple.com/gb/podcast/i...
#IDSky
This week @erinmccreary.bsky.social & @juliejusto.bsky.social from @sidpharm.bsky.social #Breakpoints podcast join Callum & Jame to show ‘em how it’s done and discuss the IDSA Difficult-to-Treat Gram Negative guidance!!
podcasts.apple.com/gb/podcast/i...
#IDSky
104. IDSA Difficult To Treat Gram negatives Guidance 2024 with Breakpoints podcast
Podcast Episode · ID:IOTS - Infectious Disease Insight Of Two Specialists · 24/03/2025 · 1h 19m
podcasts.apple.com
March 24, 2025 at 7:03 AM
IT’S A BREAKPOINTS BREAKOUT!!!
This week @erinmccreary.bsky.social & @juliejusto.bsky.social from @sidpharm.bsky.social #Breakpoints podcast join Callum & Jame to show ‘em how it’s done and discuss the IDSA Difficult-to-Treat Gram Negative guidance!!
podcasts.apple.com/gb/podcast/i...
#IDSky
This week @erinmccreary.bsky.social & @juliejusto.bsky.social from @sidpharm.bsky.social #Breakpoints podcast join Callum & Jame to show ‘em how it’s done and discuss the IDSA Difficult-to-Treat Gram Negative guidance!!
podcasts.apple.com/gb/podcast/i...
#IDSky
Reposted by Karrine Brade, PharmD
IDSA is proud to celebrate the 33 extraordinary individuals accepted into the Leadership Institute’s 2025 Community of Leaders program. Congratulations to each member of the new class on their dedication to leadership development and community building in the field of ID/HIV! #FutureofID
March 14, 2025 at 8:13 PM
IDSA is proud to celebrate the 33 extraordinary individuals accepted into the Leadership Institute’s 2025 Community of Leaders program. Congratulations to each member of the new class on their dedication to leadership development and community building in the field of ID/HIV! #FutureofID
Reposted by Karrine Brade, PharmD
Congratulations, @nicobarrosid.bsky.social, @bradeka.bsky.social, @janadickter.bsky.social, @jdfoxmd.bsky.social, @davidcgaston.bsky.social, @joelkammeyer.bsky.social, @mirellasalvatore.bsky.social, @suchindran.bsky.social, @boghuma.bsky.social, @anapaulavelez.bsky.social and @se-tid.bsky.social! 🎉
March 14, 2025 at 8:13 PM
Reposted by Karrine Brade, PharmD
Real-World Applications of Imipenem/Cilastatin/Relebactam: Insights from a Multicenter Observational Cohort Study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Real-World Applications of Imipenem/Cilastatin/Relebactam: Insights from a Multicenter Observational Cohort Study
Multidrug-resistant (MDR) Gram-negative infections are a substantial threat to patients and public health. Imipenem/cilastatin/relebactam (IMI/REL) is a beta-lactam/beta-lactamase inhibitor with expanded activity against MDR Pseudomonas aeruginosa and carbapenem-resistant Enterobacterales. This study aims to describe the patient characteristics, prescribing patterns, and clinical outcomes associated with IMI/REL.
buff.ly
March 5, 2025 at 10:11 PM
Real-World Applications of Imipenem/Cilastatin/Relebactam: Insights from a Multicenter Observational Cohort Study
✅ Just Accepted
#IDSky
✅ Just Accepted
#IDSky
Reposted by Karrine Brade, PharmD
"Disruptions in the workforce, even brief, can have far reaching consequences,” says IDSA member Joshua Barocas, MD.
Our press briefing explores the impact of disruptions in public health information: https://buff.ly/4k1NCg5
Our press briefing explores the impact of disruptions in public health information: https://buff.ly/4k1NCg5
February 25, 2025 at 11:38 PM
"Disruptions in the workforce, even brief, can have far reaching consequences,” says IDSA member Joshua Barocas, MD.
Our press briefing explores the impact of disruptions in public health information: https://buff.ly/4k1NCg5
Our press briefing explores the impact of disruptions in public health information: https://buff.ly/4k1NCg5
Reposted by Karrine Brade, PharmD
A groundbreaking study led by @jabarocas.bsky.social and published in the American Academy of Pediatrics revealed that 25% of youth experienced homelessness in Denver in 2021—a troubling trend that's been rising since 2017. https://buff.ly/4h4Lbaw
Study Finds 25% of Youth Experienced Homelessness in Denver in 2021, Significantly Higher Than Known Counts
Study Finds 25% of Youth Experienced Homelessness in Denver in 2021, Significantly Higher Than Known Counts
buff.ly
January 30, 2025 at 4:33 PM
A groundbreaking study led by @jabarocas.bsky.social and published in the American Academy of Pediatrics revealed that 25% of youth experienced homelessness in Denver in 2021—a troubling trend that's been rising since 2017. https://buff.ly/4h4Lbaw
Reposted by Karrine Brade, PharmD
ONE ANTIBIOTIC PK TABLE TO RULE THEM ALL
Absorption takes drug into blood from GI,
Vd spreads drug out to where bug calls home.
And after bacteria are doomed to die,
The drug’s eliminated on the porcelain throne
In the Land of Notion where this table doth lie…
#idSky #microsky #pharmsky #medsky
Absorption takes drug into blood from GI,
Vd spreads drug out to where bug calls home.
And after bacteria are doomed to die,
The drug’s eliminated on the porcelain throne
In the Land of Notion where this table doth lie…
#idSky #microsky #pharmsky #medsky
January 26, 2025 at 7:48 PM
January 25, 2025 at 11:42 PM
Reposted by Karrine Brade, PharmD
PJIs & biofilm’s still keeping you up at night? Dr. Julie Ann Justo is joined by Dr’s Nicolas Cortes-Penfield, Jessica Seidelman, & Kerry LaPlante to discuss using abx to help treat these infections in the latest breakpoint episode # 110 “A Bone to Pick: Biofilm Busters for PJIs”. Listen today!
January 24, 2025 at 10:00 AM
PJIs & biofilm’s still keeping you up at night? Dr. Julie Ann Justo is joined by Dr’s Nicolas Cortes-Penfield, Jessica Seidelman, & Kerry LaPlante to discuss using abx to help treat these infections in the latest breakpoint episode # 110 “A Bone to Pick: Biofilm Busters for PJIs”. Listen today!
Reposted by Karrine Brade, PharmD
We are living in perilous times. Our research lab @cudeptofmedicine.bsky.social is hiring. Looking for someone who wants to make a positive impact in the lives of ppl who are marginalized! Spread the word!
cu.taleo.net/careersectio...
cu.taleo.net/careersectio...
Information Science Professional (Entry – Senior Level) – Data Simulation Modeling
Click the link provided to see the complete job description.
cu.taleo.net
January 18, 2025 at 12:37 AM
We are living in perilous times. Our research lab @cudeptofmedicine.bsky.social is hiring. Looking for someone who wants to make a positive impact in the lives of ppl who are marginalized! Spread the word!
cu.taleo.net/careersectio...
cu.taleo.net/careersectio...
Reposted by Karrine Brade, PharmD
Summary of new antibiotic agents for the treatment of MDR Gram negative bacterial infections
doi.org/10.1016/S014...
#IDSky
doi.org/10.1016/S014...
#IDSky
January 17, 2025 at 12:46 PM
Summary of new antibiotic agents for the treatment of MDR Gram negative bacterial infections
doi.org/10.1016/S014...
#IDSky
doi.org/10.1016/S014...
#IDSky